Inhaled budesonide could become first treatment in early stages of infection if study confirmed
A cheap and widely available asthma drug appears to significantly reduce the risk of people getting seriously ill with Covid-19, if it is taken within the first week of developing symptoms, research suggests.
If the results are confirmed by other ongoing studies, inhaled budesonide – which both stops people from getting worse and shortens the length of their illness – could become the first treatment in the early stages of infection.
